RSV Vaccine Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Why RSV Protection for Infants in Canada Demands Awareness, Equity and Preparedness

December 3, 2025

National Immunization Awareness Month 2025: Exploring Vaccine Innovation

International Day of Epidemic Preparedness 2024: Amplifying Global Resilience

December 23, 2024

Pfizer’s New RSV Vaccine TV Commercial Calls for Protecting Moments

November 15, 2024

Arexvy Shows Strong Efficacy Over Three RSV Seasons in New Phase III Data

October 11, 2024

Clesrovimab Shows Promise for RSV in Infants

Moderna’s mRESVIA Wins FDA Approval as First mRNA RSV Vaccine

Arexvy Versus Abrysvo: How Do The RSV Vaccines Compare?

February 20, 2024

GSK’s Arexvy Leads Over Pfizer’s Abrysvo in Year One of RSV Vaccine Market Battle

February 5, 2024

FDA Considers Self Administered Nasal Flu Vaccine + Wayne Gretzky Features in GSK RSV Vaccine Ad – Xtalks Life Science Podcast Ep. 135

November 8, 2023

GSK Canada’s New RSV Vaccine Ad Features Wayne Gretzky, Young and Old

October 31, 2023

Pfizer’s RSV Vaccine Abrysvo Is a New Step for RSV Prevention

Arexvy Becomes World’s First RSV Vaccine

FDA Approves First Drug to Delay T1D + Positive Data for Pfizer’s Maternal RSV Vaccine – Xtalks Life Science Podcast Ep. 87

November 23, 2022